Filing Details
- Accession Number:
- 0001179110-11-015214
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-16 11:13:29
- Reporting Period:
- 2011-11-15
- Filing Date:
- 2011-11-16
- Accepted Time:
- 2011-11-16 11:13:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 855654 | Immunogen Inc | IMGN | Pharmaceutical Preparations (2834) | 042726691 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236371 | D Gregory Perry | C/O Immunogen, Inc. 830 Winter Street Waltham MA 02451 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-15 | 8,333 | $4.32 | 8,333 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-11-15 | 8,333 | $12.58 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2011-11-15 | 8,333 | $4.32 | 8,333 | $4.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 75,002 | 2010-01-09 | 2019-01-09 | No | 4 | M | Direct |
Footnotes
- Exercisable as to 31,250 shares commencing on January 9, 2010, and as to 7,812.5 shares on each April 9th, July 9th, October 9th, and January 9th thereafter, beginning on April 9, 2010.
- Weighted average price of shares sold.
- The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on May 23, 2011.
Billionaire Hedge Funds
